US Broker Ratings

Indivior PLC (INDV) Stock Analysis: High Buy Ratings and a Strong Growth Trajectory

For investors eyeing potential growth within the healthcare sector, Indivior PLC (NASDAQ: INDV) presents a compelling case. Specializing in the development and manufacture of buprenorphine-based prescription..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 51% Upside Potential in the Healthcare Sector

UFP Technologies, Inc. (NASDAQ: UFPT), a prominent player in the healthcare sector, specifically in the medical devices industry, has captured investor interest with an impressive potential..

Kestra Medical Technologies (KMTS): Investor Outlook with a 53.4% Revenue Growth Amid a Promising Upside

As the healthcare sector continues to evolve with technological advancements, Kestra Medical Technologies, Ltd. (KMTS) emerges as a noteworthy player with its innovative approach in the..

BioLife Solutions, Inc. (BLFS): Investor Outlook Reveals 30% Potential Upside

BioLife Solutions, Inc. (NASDAQ: BLFS) stands as a pivotal player in the healthcare sector, specifically in the medical instruments and supplies industry. With its headquarters in..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating a Challenging Landscape with Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, is navigating a complex yet potentially rewarding landscape. As a leader in the..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Evaluating an 82.66% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX) may not currently be the most glamorous name in the stock market, but with a potential upside of 82.66%, investors looking..

Mineralys Therapeutics, Inc. (MLYS) Investor Outlook: A 37.77% Potential Upside in Biotechnology

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) presents a compelling opportunity for investors with a notable potential upside of 37.77%. With a current market cap of $2.85 billion,..

Disc Medicine, Inc. (IRON) Stock Analysis: A Promising 30% Upside in the Biotech Sector

For individual investors with a keen interest in the biotechnology sector, Disc Medicine, Inc. (NASDAQ: IRON) presents an intriguing opportunity. With a market capitalization of $3.47..

Dyne Therapeutics Inc. (DYN) Stock Analysis: Unpacking a Potential 98% Upside in Biotech Innovation

Dyne Therapeutics, Inc. (NASDAQ: DYN), a burgeoning player in the biotechnology sector, is gaining traction among investors seeking promising opportunities in the healthcare industry. With a..

89bio, Inc. (ETNB) Stock Analysis: Exploring a Potential 104.68% Upside in the Biotech Arena

Investors with an eye for innovation in the healthcare sector may find 89bio, Inc. (NASDAQ: ETNB) a compelling addition to their portfolios. As a clinical-stage biopharmaceutical..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a 15% Potential Upside Amidst Mixed Financial Metrics

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a key player in the healthcare sector, specifically within the medical devices industry, presents a fascinating scenario for investors. With..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Assessing a 25.25% Potential Upside in the Medical Instruments Sector

For investors looking to dive into the healthcare sector, LeMaitre Vascular, Inc. (NASDAQ: LMAT) presents an intriguing proposition. Specializing in the development and marketing of medical..

CG Oncology, Inc. (CGON) Stock Analysis: A 77.90% Potential Upside with Promising Clinical Trials

CG Oncology, Inc. (NASDAQ: CGON), a pioneering name in the biotechnology sector, has made significant strides in developing bladder cancer therapies. With a market capitalization of..

Denali Therapeutics (DNLI) Rating Update: Exploring an 85% Potential Upside in Neurodegenerative Treatments

Denali Therapeutics Inc. (NASDAQ: DNLI), a prominent player in the biotechnology sector, is capturing investor attention with its promising pipeline of treatments targeting neurodegenerative and lysosomal..

Edgewise Therapeutics, Inc. (EWTX) Investor Outlook: A Compelling 59% Potential Upside in the Biotech Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a promising player in the biotechnology sector, has caught the attention of investors with a substantial market cap of $2.53 billion..

Harrow, Inc. (HROW) Stock Analysis: A 54.54% Potential Upside Ignites Investor Interest

For investors with an eye on the healthcare sector, Harrow, Inc. (NASDAQ: HROW) presents a compelling opportunity. Specializing in ophthalmic pharmaceuticals, Harrow has shown significant promise..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring a Promising 44% Upside in Biotech Innovation

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is gaining attention in the biotech sector, reflecting a compelling opportunity for investors intrigued by innovative healthcare solutions. With its robust..

Surgery Partners, Inc. (SGRY) Investor Outlook: Exploring a Potential 66% Upside

Surgery Partners, Inc. (SGRY), listed on the U.S. healthcare sector under the medical care facilities industry, stands out for its potential upside of 66.63% according to..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Navigating Growth with a 19.80% Upside Potential

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH), a prominent player in the healthcare industry, has positioned itself as a pivotal provider of home-based healthcare services. With a..

AtriCure, Inc. (ATRC) Stock Analysis: Strong Buy Ratings Signal Potential 27.52% Upside for Investors

AtriCure, Inc. (NASDAQ: ATRC), a key player in the healthcare sector specializing in medical instruments and supplies, is capturing investor interest with its promising growth prospects..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds